An international, multicenter, randomized, evaluator-blinded, no-treatment controlled, parallel-group study to assess the efficacy and safety of once daily nitisinone in patients with alkaptonuria after 12 months of treatment, followed by an additional 36-month treatment period
Latest Information Update: 20 Dec 2019
At a glance
- Drugs Nitisinone (Primary)
- Indications Alkaptonuria
- Focus Registrational; Therapeutic Use
- 20 Dec 2019 Status changed from active, no longer recruiting to completed.
- 06 Jun 2019 This trial has been completed in Slovakia, according to European Clinical Trials Database.
- 28 Jan 2016 Status changed from recruiting to active, no longer recruiting as per United Kingdom Clinical Research Network.